PEA for Flu, Colds, COVID & Long COVID: The Supplement That Worked Too Well? | LYLL #260

Dr. Garrett Smith introduces Palmitoylethanolamide (PEA), highlighting that while research shows it can prevent colds and the flu, its history is complicated by suppression and the promotion of 'patented' micronized versions.

Discussion of historical research, including Spanish government reimbursement program, showing PEA's long-standing efficacy as a preventative measure for respiratory infections in thousands of patients.

Dr. Smith explains why he recommends against micronized or ultramicronized PEA, citing potential contamination with additives like polyvinyl pyrrolidone (PVP) and the unnecessary heat processing of these lipid-based compounds.

Exploration of PEA's role in addressing long-COVID symptoms, neuroinflammation, and how it modulates mass cell activation, which the doctor links to his 'toxic bile paradigm'.

Guidance on appropriate dosing, differentiating between PEA and Phenyl ethylamine (PEA), and personal anecdotes regarding the use of PEA as a tool for health despite mainstream opposition.